Vaxcyte's Chief Technical Ops Officer Sells Shares
Focused on next-generation vaccines for bacterial diseases, this biotech just reported a notable insider sale amid a challenging year.
Harpreet S. Dhaliwal, Chief Technical Ops Officer of Vaxcyte (NASDAQ:PCVX), disposed of 9,743 shares in an open-market sale valued at approximately $454,891 according to the SEC Form 4 filing.
Transaction value based on SEC Form 4 weighted average purchase price ($46.69); post-Transaction value based on Jan. 2 market close ($46.46).
Source Fool.com


